Table 1.
Demographic and clinic characteristics of new cases of breast, prostate and cervical cancer in Colombia 2018a
| Variables | Type of cancer | ||
|---|---|---|---|
| Breast (n = 4855) |
Prostate (n = 2617) |
Cervical (n = 1930) |
|
| Age, yearsb | 57 (47–66) | 68 (62–74) | 47 (37–59) |
| Age categories, years | |||
| 0–9 | 0 (0.00) | 1 (0.04) | 0 (0.00) |
| 10–19 | 1 (0.02) | 0 (0.00) | 1 (0.05) |
| 20–29 | 75 (1.54) | 0 (0.00) | 125 (6.48) |
| 30–39 | 389 (8.01) | 0 (0.00) | 497 (25.75) |
| 40–49 | 1004 (20.68) | 42 (1.60) | 474 (24.56) |
| 50–59 | 1349 (27.79) | 355 (13.57) | 377 (19.53) |
| 60–69 | 1216 (25.05) | 1074 (41.04) | 257 (13.32) |
| 70–79 | 592 (12.19) | 876 (33.47) | 141 (7.31) |
| 80+ | 229 (4.72) | 269 (10.28) | 58 (3.01) |
| Region | |||
| Central | 1522 (31.35) | 776 (29.65) | 513 (26.58) |
| Bogotá D.C. | 1104 (22.74) | 654 (24.99) | 400 (20.73) |
| Pacific | 810 (16.68) | 462 (17.65) | 377 (19.53) |
| Caribbean | 827 (17.03) | 411 (15.71) | 356 (18.45) |
| Eastern | 544 (11.20) | 295 (11.27) | 217 (11.24) |
| Other departments | 48 (0.99) | 19 (0.73) | 67 (3.47) |
| Health insurance | |||
| Contributory | 3265 (67.25) | 1768 (67.56) | 857 (44.40) |
| Subsidized | 1351 (27.83) | 663 (25.33) | 1025 (53.11) |
| Exception | 178 (3.67) | 96 (3.67) | 32 (1.66) |
| Special | 52 (1.07) | 88 (3.36) | 12 (0.62) |
| Uninsured | 9 (0.19) | 2 (0.08) | 4 (0.21) |
| Invasive cancer (yes) | 4506 (92.81) | 2593 (99.08) | 1425 (73.83) |
| Staging (yes) | 4503 (92.75) | 1903 (72.72) | 1814 (93.99) |
| Clinical stage | |||
| In situ | 419 (8.63) | 42 (1.60) | 535 (27.72) |
| Stage I | 904 (18.62) | 514 (19.64) | 434 (22.49) |
| Stage II | 1759 (36.23) | 773 (29.54) | 366 (18.96) |
| Stage III | 1148 (23.65) | 190 (7.26) | 392 (20.31) |
| Stage IV | 273 (5.62) | 384 (14.67) | 87 (4.51) |
| No data | 352 (7.25) | 714 (27.28) | 116 (6.01) |
| Treatment | |||
| Systemic therapy | 3112 (64.10) | 926 (35.38) | 614 (31.81) |
| Radiotherapy | 714 (14.71) | 582 (22.24) | 603 (31.24) |
| Surgery | 2033 (41.87) | 751 (28.70) | 636 (32.95) |
| Care opportunityb | |||
| Clinical suspicion to diagnosis | 35 (18–68) | 39 (20–90) | 34 (15–76) |
| Diagnosis to treatment | 59 (36–91) | 71 (35–114) | 71 (42–105) |
aIncludes invasive and in situ tumors. Data are presented as absolute values (proportions), unless otherwise specified
bReported values are medians (interquartile ranges)